-
Rho Announces Fifth Year as Smile Train Triathlon Title Sponsor
Feb 17, 2020, 13:34 PM by Michael CroftDURHAM, NC, UNITED STATES - Feb 17, 2020 - For Immediate Release Rho Announces Fifth Year as Smile Train Triathlon Title Sponsor The RTP-based Contract Research Organization will continue to show its support at the charity's 13th annual event in Wake Forest Research Triangle Park, NC ̶ February 17, 2020 ̶ Rho, an RTP-based full-service contract research organization (CRO) focused on bringing new products to market through a complete range of product development services, today announced it is the 2020 Title Sponsor of the 13th annual Smile Train Triathlon, taking place Sunday, June 28 in Wake Forest, North CarolinaFull story -
Stevanato Group partners with Pfeiffer Vacuum to deliver effective biopharma industry testing
Feb 17, 2020, 06:20 AM by Michael CroftPIOMBINO DESE, PADUA AND INDIANAPOLIS, ITALY - Feb 17, 2020 - Stevanato Group has announced a new partnership with Pfeiffer Vacuum Technologies to provide biopharma companies with advanced Container Closure Integrity (CCI) analysis and testing protocolsFull story -
NVIDIA DGX-2 Systems Supplied by Microway Accelerate Research at Oak Ridge National Laboratory
Feb 14, 2020, 13:27 PM by Michael CroftPLYMOUTH, MA, UNITED STATES - Feb 14, 2020 - Microway, a leading provider of computational clusters, servers, and workstations for AI and HPC, announces it has delivered 2 NVIDIA DGX-2 AI Systems to the US Department of Energy’s Oak Ridge National Laboratory (ORNL) that have since opened new opportunities and scientific results for machine learning and data-intensive computing groupsFull story -
NicheNet: New Tool For Decoding Intercellular Communication
Feb 14, 2020, 12:40 PM by Michael CroftFull storyBio-IT World | A new bioinformatics method couples Google’s most famous search result ranking algorithm with a parameter optimization technique powered by machine learning to give researchers a better picture of intercellular communication—including the effects of extracellular signals (called ligands) on the gene expression of other cells.
-
2 Industry Veterans Join TrialScope Connect™ Advisory Board
Feb 13, 2020, 12:30 PM by Michael CroftJERSEY CITY, NJ, US - Feb 13, 2020 - TrialScope announces the appointment of Craig Lipset and Scott Ballenger to the TrialScope Connect advisory boardFull story -
The Open Wearables Initiative Expands Founding Team; Begins Soliciting Algorithms and Datasets for Wearable and Connected Health Technologies
Feb 13, 2020, 08:11 AM by Michael CroftCAMBRIDGE, MA - Feb 13, 2020 - Shimmer Research, a global leader in wearable technology for research applications, today announced that the Open Wearables Initiative (OWEAR) is now actively soliciting open source software and datasets from wearable sensors and other connected health technologies at wwwFull story -
Domainex announces the appointment of Tom Mander as Chief Executive Officer
Feb 13, 2020, 05:25 AM by Michael CroftCAMBRIDGE, UK - Feb 13, 2020 - Domainex Ltd is pleased to announce the appointment of Dr Tom Mander as Chief Executive Officer. Dr Mander will take over when Dr Trevor Perrior retires from the role in April 2020Full story -
XTREME-D Launches New HPC Infrastructure Services in Collaboration with Digital Realty, Announces Strategic Alliance with Lenovo
Feb 12, 2020, 17:39 PM by Michael CroftTOKYO, JAPAN AND PALO ALTO, CALIFORNIA - Feb 12, 2020 - Award-winning Japanese HPC Cloud company XTREME-D today announced an agreement with San Francisco-based Digital Realty (NYSE: DLR), a leading global provider of data center, colocation, and interconnection solutionsFull story -
Atrius Health Engages Kyruus to Advance Novel Digital Patient Access Initiatives
Feb 12, 2020, 16:00 PM by Michael CroftBOSTON, MA, UNITED STATES - Feb 12, 2020 - Kyruus, the leader in provider search and scheduling solutions for health systems, today announced that Atrius Health, the Northeasts largest non-profit independent medical group, has selected the companys solutions to enhance patient access across Eastern MassachusettsFull story -
Stilla Technologies raises €20 million ($22 million) in Series B round that brings in new investor, TUS-Holdings, alongside existing ones
Feb 12, 2020, 14:53 PM by Michael CroftPARIS, FRANCE - Feb 11, 2020 - Stilla Technologies, a leading provider of pioneering digital PCR (dPCR) solutions for high-precision genetic analysis, has just raised €20 million ($22 million) in a Series B funding round that brought in a new investor, the Chinese group TUS-Holdings, alongside the participation of existing investors Illumina Ventures, Kurma Partners, LBO France, Paris Saclay Seed Funds, BNP Paribas Développement and Idinvest PartnersFull story -
Signant Health Unveils its full Conference Line-up for SCOPE 2020
Feb 11, 2020, 12:02 PM by Michael CroftPHILADELPHIA, PA, UNITED STATES - Feb 11, 2020 - The SCOPE Summit for Clinical Operations Executives annually convenes innovative thought leaders from across the life sciences industry to share ideas, challenges and best practices that will help drive change and improve patient centricity throughout the coming year and beyondFull story -
AbbVie’s Fresh Look At How AI And Quantum Computing Will Transform Biotech
Feb 11, 2020, 06:20 AM by Michael CroftFull storyBio-IT World | AbbVie's head of artificial intelligence and senior principal data scientist within the R&D Information Research group argues our innovations must produce value, operational first, then analytic, and finally experiential.
-
Olaris Announces Grant from The Michael J. Fox Foundation for Parkinson’s Research
Feb 10, 2020, 15:50 PM by Michael CroftWALTHAM, MA, UNITED STATES - Feb 11, 2020 - Olaris, a precision medicine company that is fundamentally changing how diseases are diagnosed and treated, today announced it has received a grant from The Michael JFull story -
Aquestive Therapeutics Announces U.S. Food and Drug Administration Filing Acceptance of New Drug Application (NDA) for Libervant™ (diazepam) Buccal Film
Feb 10, 2020, 15:17 PM by Michael CroftWARREN, NJ - Feb 10, 2020 - Aquestive Therapeutics, Inc. (AQST), a specialty pharmaceutical company focused on developing and commercializing differentiated products that address patients unmet needs and solve therapeutic problems, announced today that, as anticipated, the UFull story -
Efficient digital documentation of microscopic samples
Feb 10, 2020, 14:29 PM by Michael CroftJENA, GERMANY - Feb 10, 2020 - Smart Microscopy from ZEISS is a new concept for the routine digital documentation of microscopic samplesFull story -
Arvinas Selects Certara to Advance Speed and Efficiency of its Targeted Protein Degradation Research
Feb 10, 2020, 08:39 AM by Michael CroftPRINCETON, NJ - Feb 10, 2020 - Certara®, the global model-informed drug development and decision support leader, today announced that its discovery research relationship with Arvinas has expanded to include a greater diversity of small molecule drug discovery projects and data sourcesFull story -
Scaling Precision Oncology
Feb 7, 2020, 10:05 AM by Michael CroftFull storyBio-IT World | Kenna Mills-Shaw believes that precision oncology is neither an illusion nor a panacea. But while there have been some dramatic wins for specific, molecularly-defined tumors, scaling precision oncology will require a highly integrated decision support platform.
-
Nature Begins Publishing Peer Reviews
Feb 6, 2020, 12:50 PM by Michael CroftFull storyBio-IT World | Nature Research announced yesterday that its flagship publication, Nature, will join others in the family in publishing peer review correspondence.
-
How Wearables Will Help Us Keep Tabs On The Future Of Health
Feb 6, 2020, 12:00 PM by Michael CroftFull storyBio-IT World | In 2012, Michael Snyder created an integrative personal omics profile, an analysis that combines genomic, transcriptomic, proteomic, metabolomic, and autoantibody profiles from a single individual. Today, Snyder is incorporating data from smart watches, continuous glucose monitoring, and other wearables to track people’s health and find early signs of disease.
-
Summit Healthcare to Showcase Robotic Process Automation (RPA) Technology and Services at HIMSS20
Feb 6, 2020, 08:37 AM by Michael CroftBRAINTREE, MA - Feb 6, 2020 - Braintree, Mass., February 6, 2020 - Summit Healthcare, a leading provider of automation and healthcare systems integration technology, today announced that it will be showcasing cutting-edge Robotic Process Automation (RPA) solutions in booth #5558 at the 2020 HIMSS Global Health Conference & Exhibition, which will be held in Orlando, FL, between March 9 and March 13, 2020Full story